Faculty Profiles

Stephen Tomlanovich, MD
M_MED-NEPH-CORE-GEN
Professor

400 Parnassus Avenue
San Francisco, CA 94117
415-353-2507
Stephen.Tomlanovich@ucsf.edu

Related Web Sites

Recent Articles (26)

Qazi Y, Shaffer D, Kaplan B, Kim DY, Luan FL, Peddi VR, Shihab F, Tomlanovich S, Yilmaz S, McCague K, Patel D, Mulgaonkar S. Efficacy and Safety of Everolimus Plus Low-Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard-Dose Tacrolimus in De Novo Renal Transplant Recipients: 12-Month Data. Am J Transplant. 2017 May; 17(5):1358-1369.

O'Leary JG, Demetris AJ, Friedman LS, Gebel HM, Halloran PF, Kirk AD, Knechtle SJ, McDiarmid SV, Shaked A, Terasaki PI, Tinckam KJ, Tomlanovich SJ, Wood KJ, Woodle ES, Zachary AA, Klintmalm GB. The role of donor-specific HLA alloantibodies in liver transplantation. Am J Transplant. 2014 Apr; 14(4):779-87.

Wojciechowski D, Chanda R, Chandran S, Lee B, Webber A, Macaraig M, Tomlanovich S, Vincenti F. Ciprofloxacin prophylaxis in kidney transplant recipients reduces BK virus infection at 3 months but not at 1 year. Transplantation. 2012 Dec 15; 94(11):1117-23.

Chandran S, Baxter-Lowe L, Olson JL, Tomlanovich SJ, Webber A. Eculizumab for the treatment of de novo thrombotic microangiopathy post simultaneous pancreas-kidney transplantation--a case report. Transplant Proc. 2011 Jun; 43(5):2097-101.

Findlay JY, Fix OK, Paugam-Burtz C, Liu L, Sood P, Tomlanovich SJ, Emond J. Critical care of the end-stage liver disease patient awaiting liver transplantation. Liver Transpl. 2011 May; 17(5):496-510.

Odisho AY, Freise CE, Tomlanovich SJ, Vagefi PA. Inguinal herniation of a transplant ureter. Kidney Int. 2010 Jul; 78(1):115.

Woodle ES, Peddi VR, Tomlanovich S, Mulgaonkar S, Kuo PC. A prospective, randomized, multicenter study evaluating early corticosteroid withdrawal with Thymoglobulin in living-donor kidney transplantation. Clin Transplant. 2010 Jan-Feb; 24(1):73-83.

Tavakol MM, Vincenti FG, Assadi H, Frederick MJ, Tomlanovich SJ, Roberts JP, Posselt AM. Long-term renal function and cardiovascular disease risk in obese kidney donors. Clin J Am Soc Nephrol. 2009 Jul; 4(7):1230-8.

Bolin P, Tanriover B, Zibari GB, Lynn ML, Pirsch JD, Chan L, Cooper M, Langone AJ, Tomlanovich SJ. Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients. Transplantation. 2007 Dec 15; 84(11):1443-51.

Tomlanovich SJ, Vincenti F. Sirolimus: defining nephrotoxicity in the renal transplant recipient. Clin J Am Soc Nephrol. 2007 Mar; 2(2):198-9.

Brennan TV, Fuller TF, Vincenti F, Chan S, Chang CK, Bostrom A, Zlatunich JK, Tomlanovich SJ, Feng S. Living donor kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care. Am J Transplant. 2006 Oct; 6(10):2429-35.

Salvadori M, Holzer H, Civati G, Sollinger H, Lien B, Tomlanovich S, Bertoni E, Seifu Y, Marrast AC. Long-term administration of enteric-coated mycophenolate sodium (EC-MPS; myfortic) is safe in kidney transplant patients. Clin Nephrol. 2006 Aug; 66(2):112-9.

McTaggart RA, Tomlanovich SJ, Feng S. Impact of sirolimus on early graft function after deceased-donor kidney transplantation. Transplantation. 2005 Apr 27; 79(8):991; author reply 991-2.

Fuller TF, Feng S, Brennan TV, Tomlanovich S, Bostrom A, Freise CE. Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival. Transplantation. 2004 Oct 15; 78(7):1030-5.

McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S. Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens. Transplantation. 2004 Aug 15; 78(3):475-80.

Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlanovich SJ, Feng S. Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant. 2004 Jun; 4(6):971-9.

Topp KS, Painter PL, Walcott S, Krasnoff JB, Adey D, Sakkas GK, Taylor J, McCormick K, TeNyenhuis M, Iofina M, Tomlanovich S, Stock P. Alterations in skeletal muscle structure are minimized with steroid withdrawal after renal transplantation. Transplantation. 2003 Aug 27; 76(4):667-73.

Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, Terrault NA, Frassetto LA, Palefsky JM, Tomlanovich SJ, Ascher NL. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation. 2003 Jul 27; 76(2):370-5.

Painter P, Taylor J, Wolcott S, Krasnoff J, Adey D, Tomlanovich S, Stock P, Topp K. Exercise capacity and muscle structure in kidney recipient and twin donor. Clin Transplant. 2003 Jun; 17(3):225-30.

Painter PL, Topp KS, Krasnoff JB, Adey D, Strasner A, Tomlanovich S, Stock P. Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients. Kidney Int. 2003 Jun; 63(6):2309-16.

McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant. 2003 Apr; 3(4):416-23.

Roza A, Tomlanovich S, Merion R, Pollak R, Wright F, Rajagopalan P, Pruett T, Scandling J, Ryan J, Awni W, Schweitzer S, Greco R, Lam W, Nabulsi A, Hoffman R. Conversion of stable renal allograft recipients to a bioequivalent cyclosporine formulation. Transplantation. 2002 Oct 15; 74(7):1013-7.

Hiramoto JS, Freise CE, Randall HR, Bretan PN, Tomlanovich S, Stock PG, Hirose R. Successful long-term outcomes using pediatric en bloc kidneys for transplantation. Am J Transplant. 2002 Apr; 2(4):337-42.

Pescovitz MD, Conti D, Dunn J, Gonwa T, Halloran P, Sollinger H, Tomlanovich S, Weinstein S, Inokuchi S, Kiberd B, Kittur D, Merion RM, Norman D, Shoker A, Wilburn R, Nicholls AJ, Arterburn S, Dumont E. Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics. Clin Transplant. 2000 Jun; 14(3):179-88.

Suri DL, Tomlanovich SJ, Olson JL, Meyer TW. Transplant glomerulopathy as a cause of late graft loss. Am J Kidney Dis. 2000 Apr; 35(4):674-80.

  Select data provided by UCSF Profiles, powered by CTSI at UCSF. Learn more about the data source.